PharmaResearch Co., Ltd.

₩234,500As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:214450Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 19.50%
Div yield 1.58%
ROE 27.34%
Medical (Pharmaceuticals)
Beta (5Y) 0.57
PE TTM 14.03
TSR TTM (56.23%)
Mkt cap ₩2.436T
ROIC 49.07%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩263,233
12.25%
(58.55%)
Hold 3|10|11|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
4,056
4,235
4,184
4,124
36.46%
28.01%
13.00%
9.38%
Revenue₩B
158.3
158.3
156.0
152.8
6.04%
2.68%
0.93%
(3.03%)
Peers (US$1.796B)
Cap (US$)
PE
1.117B
19.92x
Capital
TTM
5Y
10Y
Leveragex
0.244
11.00
9.367
EBIT/Intx
1.534
0.153
0.150
Own earn%
70.40
23.29
6.86
Sh yield%
32.34
54.38
54.18
Owners
Insiders/Inst%
11.58
20.63
Short interest%
3.62
SBC / revenue%
1.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
4